If there’s one thing that remains constant in biotech, it’s the ability of companies to adapt and evolve relative to available resources and current limitations….

Demographically, South Korea has been an appealing investment opportunity for pharma companies. It has a relatively large population of around 51 million people…

The growing biopharmaceutical market in China has become increasingly appealing to international entrepreneurs and investors, with recent…